Synthesis and crystal structures of two structurally related kryptoracemates

Kryptoracemates are racemic compounds (pairs of enantiomers) that crystallize in Sohnke space groups (space groups that contain neither inversion centres nor mirror or glide planes nor rotoinversion axes). Thus, the two symmetry‐independent molecules cannot be transformed into one another by any symmetry element present in the crystal structure. Usually, the conformation of the two enantiomers is rather similar if not identical. Sometimes, the two enantiomers are related by a pseudosymmetry element, which is often a pseudocentre of inversion, because inversion symmetry is thought to be favourable for crystal packing. We obtained crystals of two kryptoracemates of two very similar compounds differing in just one residue, namely rac‐N‐[(1S ,2R ,3S )‐2‐methyl‐3‐(5‐methylfuran‐2‐yl)‐1‐phenyl‐3‐(pivalamido)propyl]benzamide, C₂₇H₃₂N₂O₃, (I), and rac‐N‐[(1S ,2S ,3R )‐2‐methyl‐3‐(5‐methylfuran‐2‐yl)‐1‐phenyl‐3‐(propionamido)propyl]benzamide dichloromethane hemisolvate, C₂₅H₂₈N₂O₃·0.5CH₂Cl₂, (II). The crystals of both compounds contain both enantiomers of these chiral molecules. However, since the space groups [P 2₁2₁2₁ for (I) and P 1 for (II)] contain neither inversion centres nor mirror or glide planes nor rotoinversion axes, there are both enantiomers in the asymmetric unit, which is a rather uncommon phenomenon. In addition, it is remarkable that (II) contains two pairs of enantiomers in the asymmetric unit. In the crystal, molecules are connected by intermolecular N—H…O hydrogen bonds to form chains or layered structures.     

Selected Thoughts on Hydrophobicity in Drug Design

The fundamental aim of drug design in research and development is to invent molecules with selective affinity towards desired disease-associated targets. At the atomic loci of binding surfaces, systematic structural variations can define affinities between drug candidates and biomolecules, and thereby guide the optimization of safety, efficacy and pharmacologic properties. Hydrophobic interaction between biomolecules and drugs is integral to binding affinity and specificity. Examples of antiviral drug discovery are discussed.     

Electrochemical bromination of cyclic and acyclic enes using biphasic electrolysis

A simple method of electrochemical bromination of a series of cyclic and acyclic enes (styrene and substituted styrenes, stilbene, indene, and cyclooctene) in a biphasic water–chloroform mixture mediated by bromide/bromine redox system is reported. Aqueous 25% NaBr/H₂SO₄ is used as the electrolyte. Regio- and stereoselective dibromination of enes is achieved. Moderate to excellent yields of the product (83–98%) is obtained depending on the substrate. Electrolyte reuse has also been demonstrated successfully using HBr in the dibromination of styrene.     

Incorporation of Pseudo‐complementary Bases 2,6‐Diaminopurine and 2‐Thiouracil into Serinol Nucleic Acid (SNA) to Promote SNA/RNA Hybridization

Serinol nucleic acid (SNA) is a promising candidate for nucleic acid‐based molecular probes and drugs due to its high affinity for RNA. Our previous work revealed that incorporation of 2,6‐diaminpurine (D), which can form three hydrogen bonds with uracil, into SNA increases the melting temperature of SNA‐RNA duplexes. However, D incorporation into short self‐complementary regions of SNA promoted self‐dimerization and hindered hybridization with RNA. Here we synthesized a SNA monomer of 2‐thiouracil (sU), which was expected to inhibit base pairing with D by steric hindrance between sulfur and the amino group. To prepare the SNA containing D and sU in high yield, we customized the protecting groups on D and sU monomers that can be readily deprotected under acidic conditions. Incorporation of D and sU into SNA facilitated stable duplex formation with target RNA by suppressing the self‐hybridization of SNA and increasing the stability of the heteroduplex of SNA and its complementary RNA. Our results have important implications for the development of SNA‐based probes and nucleic acid drugs.     

Totally acyclic complexes over noetherian schemes

We define a notion of total acyclicity for complexes of flat quasi-coherent sheaves on a semi-separated noetherian scheme, and study these complexes using the pure derived category of flat quasi-coherent sheaves. We prove that a scheme is Gorenstein if and only if every acyclic complex of flat quasi-coherent sheaves is totally acyclic. Our formalism also removes the need for a dualising complex in several known results for rings, including Jørgensen's proof of the existence of Gorenstein projective precovers.     

含POSS侧基的非环二烯烃易位聚合及离子型杂化聚合物表征

基于七异丁基-胺丙基-多面体低聚倍半硅氧烷(POSS-NH₂)与溴丁烯或溴代十一烯反应, 一步法合成了含POSS侧基的两种杂化二烯烃. 以钌卡宾络合物为催化剂的非环二烯烃易位(ADMET)聚合, 短链二烯烃未能发生, 而长链二烯烃能顺利实现. 将杂化二烯烃转变为离子型杂化二烯烃, 其ADMET聚合活性较高, 随着反应时间延长, 聚合物分子量明显增大, 分子量分布变窄, 体现了逐步聚合的特征. 核磁共振分析揭示了聚合物的不饱和结构和聚合反应的变化过程. 主链不饱和的无定形聚合物, 经氢化作用转变为饱和的离子型杂化聚乙烯, POSS基团精确地连接在聚乙烯骨架的侧位上, 且POSS基团和聚乙烯骨架均表现出较强的结晶能力. 这种离子型杂化聚乙烯具有球形的单分子或聚集形态, 可直接构筑纳米尺度的聚合物材料.     

A new characterization of for countable spectra of (LB)-spaces

The derived projective limit functor Proj¹ is a very useful tool for investigating surjectivity problems in various parts of analysis (e.g. solvability of partial differential equations).

We provide a new characterization for vanishing Proj¹ on projective spectra of (LB)-spaces which improves a classical result of V. P. Palamodov and V. S. Retakh.

     

Maximum directed cuts in digraphs with degree restriction

For integers m, k≥1, we investigate the maximum size of a directed cut in directed graphs in which there are m edges and each vertex has either indegree at most k or outdegree at most k. © 2009 Wiley Periodicals, Inc. J Graph Theory